Table 1

Baseline characteristics in patients with type 1 diabetes (n = 236) and control subjects (n = 78)

Type 1 diabetic subjectsControl
subjectsP
Total population236 (100)78 (100)
 Female106 (45)44 (56)
 Male130 (55)34 (44)
Age (years)44 ± 1349 ± 100.008
 Female44 ± 1348 ± 100.052
 Male44 ± 1349 ± 100.071
BMI (kg/m2)24.8 ± 4.124.6 ± 3.20.60
 Female24.1 ± 4.524.2 ± 3.40.51
 Male25.5 ± 3.625.2 ± 2.90.91
Waist-to-hip ratio0.88 ± 0.10.85 ± 0.070.009
 Female0.82 ± 0.080.81 ± 0.070.42
 Male0.93 ± 0.080.90 ± 0.050.05
Smokers35 (15)15 (19)0.48
Systolic BP (mmHg)128 ± 18124 ± 120.04
Diastolic BP (mmHg)73 ± 977 ± 8<0.001
S-creatinine (mmol/L)77 ± 2075 ± 120.44
P-glucose (mmol/L)10.2 ± 4.55.1 ± 0.5<0.001
Total cholesterol (mmol/L)4.5 ± 0.85.2 ± 0.7<0.001
Triglycerides (mmol/L)0.81 ± 0.70.84 ± 0.40.74
LDL cholesterol (mmol/L)2.6 ± 0.73.4 ± 0.7<0.001
HDL cholesterol (mmol/L)1.7 ± 0.51.6 ± 0.40.07
ACE inhibitors63 (27)1 (1)
Statins76 (32)1 (1)
Estrogens, n/N total females in each group (%)15/106 (14)4/44 (9)
  • Data are means ± SD or n (%) unless otherwise indicated. No patients were on aspirin or anticoagulants. BP, blood pressure; P-glucose, plasma glucose.